Innovating.works Conecta tu I+D

ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado

B-ACTIVE: Training of young scientists in the Biological regulation of the chemokine network to improve treatm... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un HORIZON EUROPE: HORIZON-MSCA-2022-DN-01 A number of pharmaceuticals targeting cytokine/chemokine storms in lungs are in development due to an urgent new unmet medical need strength...
2023-07-05 - 2027-12-31 | Financiado

PROMINENT: PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million...
2023-04-25 - 2028-04-30 | Financiado

METHYLOMIC: DNA methylation markers to predict treatment success of biologicals in Crohn’s disease. UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-11 Monoclonal antibodies have become a mainstay of therapy in common immune-mediated diseases (IMID) including Crohn’s disease (CD), rheumatoid...
2022-11-24 - 2026-12-31 | Financiado

SUNRISE: Strategies and Technologies for United and Resilient Critical Infrastructures and Vital Services in... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un HORIZON EUROPE: HORIZON-CL3-2021-INFRA-01 The COVID-19 pandemic has highlighted the importance of the continuity of vital services, has shown the need to work together for the common...
2022-09-06 - 2025-09-30 | Financiado

FORTEe: Get strong to fight childhood cancer an exercise intervention for children and adolescents undergoi... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020: H2020-SC1-BHC-2018-2020 Cancer is the first leading cause of death by non-communicable diseases in children in Europe. During cancer treatment, patients’ morbidity...
2021-02-03 - 2026-08-31 | Financiado

ENVISION: Intelligent plug and play digital tool for real time surveillance of COVID 19 patients and smart dec... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020: H2020-SC1-PHE-CORONAVIRUS-2020-2 Within only six months, over 7.4 million people have been diagnosed with SARS-CoV-2. In the most severely hit countries, more than 10% of in...
2020-10-13 - 2023-07-31 | Financiado

DIAMONDS: Diagnosis and Management of Febrile Illness using RNA Personalised Molecular Signature Diagnosis UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020: H2020-SC1-BHC-2018-2020 Our proposal will address the challenge of bringing personalised medicine into routine use in EU healthcare systems for diagnosis and treatm...
2019-12-06 - 2025-06-30 | Financiado

EJP RD: European Joint Programme on Rare Diseases UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020: H2020-SC1-BHC-2018-2020 As recognized by the Council Recommendation 2009/C 151/02, rare diseases (RD) are a prime example of a research area that can strongly profi...
2018-12-13 - 2024-08-31 | Financiado

ImmunAID: Immunome project consortium for AutoInflammatory Disorders UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020: H2020-SC1-2016-2017 Systemic autoinflammatory diseases (SAID) encompass several rare disorders characterised by extensive clinical and biological inflammation....
2018-04-27 - 2024-10-31 | Financiado

HBM4EU: European Human Biomonitoring Initiative UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020: H2020-SC1-2016-2017 The overarching goal of the European Human Biomonitoring Initiative (HBM4EU) is to generate knowledge to inform the safe management of chemi...
2016-12-09 - 2022-06-30 | Financiado

MOPEAD: Models Of Patient Engagement for Alzheimer s Disease Sofia ref. 115985 UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020: H2020-JTI-IMI2-2015-05-two-stage The MOPEAD consortium has proposed a programme of work carefully aligned to the objectives of IMI2 Call to deliver a step-change in AD-relat...
2016-12-07 - 2019-12-31 | Financiado

PERFORM: Personalised Risk assessment in febrile illness to Optimise Real life Management across the European... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020: H2020-PHC-2014-2015 The management of febrile patients is one of the most common and important problems facing healthcare providers. Distinction between bacteri...
2015-12-01 - 2021-06-30 | Financiado

EUthyroid: Towards the elimination of iodine deficiency and preventable thyroid related diseases in Europe UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020: H2020-PHC-2014-2015 Despite the fact that iodine deficiency (ID) can easily be prevented by iodine fortification of table salt, industrial salt and cattle food,...
2015-04-08 - 2018-05-31 | Financiado

SCIENCE: Stem Cell therapy in IschEmic Non treatable Cardiac diseasE SCIENCE UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un H2020: H2020-PHC-2014-2015 Stem Cell therapy in IschEmic Non-treatable Cardiac diseasE (SCIENCE) With more than 17 million deaths worldwide each year, ischemic heart...
2014-12-03 - 2020-12-31 | Financiado

TARCC: Targeting alpha particle emitting radionuclides to combat cancer UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un FP7: This project aims at improving drug delivery to cancer cells by developing targeted radiotherapy with alpha-emitting radionuclides. Alpha pa...
Financiado

ARCH: Patient specific image based computational modelling for nimprovement of short and long term outco... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un FP7: More than half a million people live in Europe on chronic renal replacement therapy by hemodialysis (HD). This number increases annually at...
Financiado

CREACTIVE: Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un FP7: Traumatic brain injury (TBI) is among the leading causes of death and disability and the main cause of death among the under-45s. Most patie...
Financiado

CULPRIT-SHOCK: Multivessel versus culprit lesion only percutaneous revascularization in patients with acute myocard... UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un FP7: Cardiogenic shock (CS) complicating acute myocardial infarction (AMI) represents a major European health care concern with mortality rates b...
Financiado

RESPECT: Relating Expectations and needs to Participation and Empowerment of children in Clinical Trials UNIVERZITETNI KLINICNI CENTER LJUBLJANA participó en un FP7: There are two objectives for this project, firstly to clarify the expectations and needs of children and their families who have participate...
Financiado

UKCL